Clinical pet in oncology: Not only fdg

Nuclear Medicine Communications

Volumn 27, Issue 9, 2006, Pages 685-688

  Nanni, Cristina ^a   Rubello, Domenico ^a   Al Nahhas, Adil ^a   Fanti, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3' FLUOROTHYMIDINE; 3' FLUOROTHYMIDINE F 18; 6 FLUORODOPA F 18; ACETIC ACID C 11; CARBON 11; CHOLINE C 11; CHOLINE DERIVATIVE; FLUORODEOXYGLUCOSE; GADOTERIC ACID; METHIONINE C 11; UNCLASSIFIED DRUG;

BRAIN TUMOR; CANCER DIAGNOSIS; DIAGNOSTIC IMAGING; EDITORIAL; HUMAN; LIVER TUMOR; NEUROENDOCRINE TUMOR; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

ACETATES; CARBON RADIOISOTOPES; CHOLINE; FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; HUMANS; MEDICAL ONCOLOGY; METHIONINE; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 33747043824     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000224462.44051.d2     Document Type: Editorial

References (22)

1. Sanz G, Rioja J, Zudaire JJ, Berian JM, Richter JA. PET and prostate cancer. World J Urol 2004; 22:351-352.
2. 18F]fluorodeoxyglucose-positron emission tomography. J Urol 2003; 169:1337-1340.
3. 18F]FDG with positron emission tomography in recurrence of prostate cancer. AJR Am J Roentgenol 2002; 179:482-484.
4. 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol 2003; 44:32-38.
5. Farsad M, Schiavina R, Castellucci P, Nanni C, Corti B, Martorana G, et al. Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis. J Nucl Med 2005; 46:1642-1649.
6. 18F-FDG PET. Eur J Nucl Med Mol Imaging 2005; 32:52-59.
7. 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging 2005; 32:39-51.
8. 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 2004; 45:1293-1298.
9. Geets X, Daisnea J-F, Gregoire V, Hamoir M, Lonneux M. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT. Radiother Oncol 2004; 71:267-273.
10. Ahlstrom H, Eriksson B, Bergstrom M, Bjurling P, Langstrom B, Oberg K. Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology 1995; 195:333-337.
11. 18F Dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 2001; 220:373-380.
12. 18F DOPA whole body PET - initial results. Radiology 2002; 222:507-512.
13. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003; 30:689-694.
14. Brink I, Hoegerle S, Klisch J, Bley TA. Imaging of pheochromocytoma and paraganglioma. Fam Cancer 2005; 4:61-68.
15. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 2001; 28:64-71.
16. 18F]-fluorodopamine positron emission tomography. J Clin Endocrinol Metab 2004; 88:637-641.
17. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5. Eur J Nucl Med Mol Imaging 2005; 32:724.
18. 11C-acetate. J Nucl Med 2003; 44:556-558.
19. 11C-acetate: a new tracer for the evaluation of hepatocellular carcinoma. J Nucl Med 2003; 44:222-223.
20. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med 2003; 44:213-221.
21. 18F]FLT-PET in oncology: current status and opportunities. Eur J Nucl Med Mol Imaging 2004; 31:1659-1672.
22. Lewis JS, Welch MJ. PET imaging of hypoxia. Q J Nucl Med 2001; 45:183-188.